Hyacinth J Depamphilis Hanover, PA - 17331

Hyacinth J Depamphilis is categorized under Internal Medicine Practitioners in Hanover, PA and active since 2005.

Hyacinth J Depamphilis was established in 2005, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 621111 by the NAICS.

If you are seeking more information, feel free to contact Hyacinth J Depamphilis at the company’s single location by writing to 795 Cherry Tree Court # 3, Hanover, Pennsylvania PA 17331 or by phoning (925) 932-6465. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Hyacinth J Depamphilis
Contact Person: Hyacinth J Depamphilis
Address: 795 Cherry Tree Court # 3, Hanover, Pennsylvania 17331
Phone Number: (925) 932-6465
Annual Revenue (USD): $100.000 to $499.999
Founded: 2005
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Practitioners
SIC Code: 8011
NAICS Code: 621111
Share This Business:

Hyacinth J Depamphilis was started in 2005 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Hyacinth J Depamphilis for inquiries that concern Hyacinth J Depamphilis by calling the company number (925) 932-6465, as your correspondence is most welcome. Additionally, the physical location of the single location of Hyacinth J Depamphilis can be found at the coordinates 39.815523,-76.964307 as well as the street address 795 Cherry Tree Court # 3 in Hanover, Pennsylvania 17331.

For its online presence, you may visit Hyacinth J Depamphilis’s website at and engage with its social media outlets through on Twitter and on Facebook.